2003
DOI: 10.1016/s0041-1345(03)00684-5
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
52
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(54 citation statements)
references
References 5 publications
0
52
0
Order By: Relevance
“…In addition, an increasing number of patients, particularly transplanted individuals, have iatrogenically induced immunodeficiency. Finally, a variety of reports stress the importance of VZV as the agent of opportunistic infection (8,14,20) The use of certain potent immunosuppressive drugs, such as mycophenolate mofetil, seems to increase the incidence of VZV infections, reinforcing the need for prompt and better control of these infections (8). Also, the treatment of chronic myelogenous leukemia may be associated with a low incidence of VZV infections (11).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, an increasing number of patients, particularly transplanted individuals, have iatrogenically induced immunodeficiency. Finally, a variety of reports stress the importance of VZV as the agent of opportunistic infection (8,14,20) The use of certain potent immunosuppressive drugs, such as mycophenolate mofetil, seems to increase the incidence of VZV infections, reinforcing the need for prompt and better control of these infections (8). Also, the treatment of chronic myelogenous leukemia may be associated with a low incidence of VZV infections (11).…”
Section: Discussionmentioning
confidence: 99%
“…Actually, MMF therapy has been related to several infections, sometimes life-threatening, by viruses like cytomega lovirus, poliomavirus, varicella (80,81). The infection risk would be higher compared to that of patients on azathioprine (80,82).…”
Section: Severe Adverse Eventsmentioning
confidence: 99%
“…Whereas prior reports indicated dissemination in up to 33% of renal transplant recipients (43), most recent studies (37-40) do not describe clinical dissemination. Visceral dissemination in the immunosuppressed transplant recipient ( Figure 2C), whether due to primary infection in adults or reactivation, is a life-threatening emergency (44)(45)(46). The clinical syndrome includes fever, abdominal pain, disseminated intravascular coagulation and hepatitis often accompanied by pneumonitis and pancreatitis.…”
Section: Clinical Manifestations Of Vzv Diseasementioning
confidence: 99%